We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 63

EPO Enlarged Board of Appeal rejects patent that requires human embryos for implementation

  • Bird & Bird
  • -
  • United Kingdom
  • -
  • December 31 2008

In its decision of 25 November 2008 the EPO Enlarged Board of Appeal (EBA) considered four questions referred to it by the EPO Technical Board of Appeal concerning a patent application by Wisconsin Alumni Research Foundation (WARF) with claims to “a cell culture comprising primate embryonic stem cells…”

UK Patents Court judgment in Dr Reddy’s Laboratories v Eli Lilly

  • Bird & Bird
  • -
  • United Kingdom
  • -
  • December 31 2008

In a judgment handed down in October of this year, the Patents Court (Mr Justice Floyd) upheld EP (UK) 0,454,436 (the “Patent”) which is owned by Eli Lilly and which protects the schizophrenia drug olanzapine

Status of the insufficiencyobviousness squeeze - an appraisal of the House of Lords’ Generics et al v Lundbeck judgments

  • Bird & Bird
  • -
  • United Kingdom
  • -
  • May 1 2009

In February 2009 the House of Lords unanimously dismissed an appeal by a number of pharmaceutical companies against the Court of Appeal’s decision to not revoke Lundbeck’s escitalopram patent on grounds of insufficiency

Leo v Sandoz UK Patents Court finds pseudopolymorph patent valid

  • Bird & Bird
  • -
  • United Kingdom
  • -
  • July 17 2009

In his judgment of 15 May 2009 Mr Justice Floyd considered novelty and obviousness attacks on Leo Pharma’s European Patent (UK) 0,679,154 directed to the monohydrate pseudopolymorph of the vitamin D analogue calcipotriol, which is used in the topical treatment of psoriasis

Patent decisions on patents for chiral compounds

  • Bird & Bird
  • -
  • United Kingdom
  • -
  • May 13 2009

A chiral compound is one which has at least one asymmetric carbon centre

Court of Appeal decides “settled” EPO case law trumps UK precedent on Swiss-type claim to a new dosage regime

  • Bird & Bird
  • -
  • United Kingdom
  • -
  • July 16 2008

The Court of Appeal has decided in the case of Actavis UK Ltd v Merck & Co Inc 2008 EWCA Civ 444, that a Swiss-type claim can be patentable where the novelty is only conferred by a new dosage regime or form of administration of a substance

Protection of dosage regiment for medicaments under the new European Patent Convention 2000

  • Bird & Bird
  • -
  • European Union
  • -
  • July 16 2008

The discussion before the European Patent Office on patentability of second medical use claims has now entered another round

The Wellcome Foundation Ltd v Paranova Pharmazeutika Handels GmbH

  • Bird & Bird
  • -
  • Austria
  • -
  • March 11 2009

Following a reference from the Austrian Supreme Court, the ECJ ruled on two questions relating to the conditions applicable to repackaging of pharmaceutical products in a parallel imports case

Commission pharma sector enquiry and initiation of formal proceedings against Servier and others

  • Bird & Bird
  • -
  • European Union
  • -
  • July 17 2009

On 8 July 2009, as this update was being finalised, the European Commission published its final report on its inquiry into the pharmaceutical sector

English Patents Court holds long-wear contact lens patent invalid for insufficiency in Novartis AG & Others v Johnson & Johnson Medical Limited & Others

  • Bird & Bird
  • -
  • United Kingdom
  • -
  • October 13 2009

In Novartis AG & Others v Johnson &Johnson Medical Limited & Others (2009EWHC 2029) the English Patents Court found that Johnson & Johnson’s product infringed the Patent, but that the Patent was invalid due to insufficiency